A bone marrow transplant is a treatment that replaces the damaged or diseased bone marrow with healthy blood-forming stem cells. A stem cell transplant is another name for a bone marrow transplant. For patients with hematologic malignancies, hematopoietic cell transplantation (HCT) is a life-prolonging or potentially curative therapy option. These therapeutic techniques were initially limited to younger patients due to the significant transplant-related morbidity, but they are increasingly being employed in older adults. The incidence of most hematologic malignancies rises with age, and as the population ages, so does the number of prospective older HCT candidates. Allogeneic haemopoietic stem cell transplantation (HSCT) is used to treat a limited number of individuals with a variety of malignant and non-malignant blood illnesses, as well as other immune system problems.
Title : Single cell multi-omics in PBMC’s
Peter J Van Der Spek, Erasmus University Medical Center, Netherlands
Title : Myeloid neoplasms and molecular genetic alterations (Germline vs Somatic) that characterize specific entities in pediatric patients
Aida I Richardson, Ann & Robert H. Lurie Children's Hospital of Chicago, United States
Title : Overview of 2021 guidelines on the diagnosis of Von Willebrand Disease (VWD)
Maryam Asif, University of Washington, United States
Title : Clonal evolution in children with inherited bone marrow failure syndromes
Raykina Elena, Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Russian Federation
Title : Defining the clinical contribution of platelet-derived FXIII-A to regulation of fibrinolysis
Fahad S Alshehri, King Faisal Medical City for Southern Region, Saudi Arabia
Title : Multiple alloantibodies: The strategy for identifying antibodies and transfusion management
Ahmed Alharbi, King Abdulaziz Medical City, Saudi Arabia